Neurocrine Biosciences | Marktkapitalisierung



Market Capitalization Veränderung Datum
AbbVie USD 370.64B 56.62B 2025-03
Acadia Pharmaceuticals USD 3.66B 889M 2025-06
Agios Pharmaceuticals USD 1.7B 178M 2025-03
ALKERMES USD 5.44B 790M 2025-03
Alnylam Pharmaceuticals USD 35.13B 4.7B 2025-03
Amgen USD 167.51B 27.54B 2025-03
Biogen USD 20.03B 2.25B 2025-03
BioMarin Pharmaceutical USD 13.56B 1.02B 2025-03
Cytokinetics USD 4.79B 759M 2025-03
Dynavax Technologies USD 1.61B 67M 2025-03
Exelixis USD 12.23B 1.9B 2025-06
Gilead Sciences USD 139.68B 24.59B 2025-03
Halozyme Therapeutics USD 7.88B 1.8B 2025-03
Incyte USD 11.72B 1.59B 2025-03
Ionis Pharmaceuticals USD 4.8B 722M 2025-03
Pfizer USD 143.72B 6.63B 2025-03
Prothena USD 745M 155M 2024-12
Sarepta Therapeutics USD 6.19B 5.59B 2025-03
Teva Pharmaceutical Industries ILS 69.56B 5.54B 2025-06
Ultragenyx Pharmaceutical USD 3.4B 485M 2025-03



Neurocrine Biosciences Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2025.